Murine asthma models have demonstrated a significant reduction in airway hyperresponsiveness, lung eosinophilia, and goblet cell metaplasia upon monoclonal antibody (mAb) blockade of IL-4Rα [19]. The gene discussed is IL4R; the disease is asthma.